Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

59:11 |

Related Videos

Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers

1:03:39

Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers

Optimal SCLC Care With Established and Innovative Therapies

1:27:09

Optimal SCLC Care With Established and Innovative Therapies

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

1:23:36

Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

49:39

Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care

1:06:54

Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care

The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals

57:49

The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals

Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

59:12

Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer

Building on the Immunotherapy Foundation for Head and Neck Cancer

1:16:37

Building on the Immunotherapy Foundation for Head and Neck Cancer

Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY

1:01:05

Watch Dr. Ramalingam discuss the latest #NSCLC updates from #WCLC24 - https://bit.ly/24Stage3LungY

Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY

1:38:45

Watch Dr. Liu discuss #NSCLC updates from #ASCO24 - https://bit.ly/2024BiomarkersY

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine

1:06:30

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine

Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted Agents

1:01:07

Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted Agents

Decoding Biomarker Testing and Targeted Therapy in NSCLC

1:25:15

Decoding Biomarker Testing and Targeted Therapy in NSCLC

REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE

36:08

REVIVE Initiative: Reinforcing Evidence-Based Principles Against Cancer-Associated VTE

Watch Drs. Tawbi & Blank discuss #Melanoma updates from #ASCO24 - https://bit.ly/2024MelanomaY

58:20

Watch Drs. Tawbi & Blank discuss #Melanoma updates from #ASCO24 - https://bit.ly/2024MelanomaY

Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies

56:08

Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies

Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations

39:06

Expanding the Benefits of Immuno-Oncology Through Novel Rational Targets and Combinations

Advancing Personalized Care in RCC

1:29:00

Advancing Personalized Care in RCC

Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations

52:36

Making Precision Decisions in the Treatment of NSCLC With Common and Uncommon EGFR Mutations

Catalysts for Change in Gastric & GEJ Cancer

1:35:13

Catalysts for Change in Gastric & GEJ Cancer